Chloroquine enhances the efficacy of chemotherapy drugs against acute myeloid leukemia by inactivating the autophagy pathway.

[1]  Nadezhda T. Doncheva,et al.  The STRING database in 2023: protein–protein association networks and functional enrichment analyses for any sequenced genome of interest , 2022, Nucleic Acids Res..

[2]  J. Rong,et al.  Pharmacological Modulation of Cardiac Remodeling after Myocardial Infarction , 2020, Oxidative medicine and cellular longevity.

[3]  D. Gewirtz,et al.  Triangular Relationship between p53, Autophagy, and Chemotherapy Resistance , 2020, International journal of molecular sciences.

[4]  M. Alcalay,et al.  Has Drug Repurposing Fulfilled Its Promise in Acute Myeloid Leukaemia? , 2020, Journal of clinical medicine.

[5]  Yuguang Ye,et al.  Inhibition LC3B can increase chemosensitivity of ovarian cancer cells , 2019, Cancer Cell International.

[6]  Zhi-chao Wang,et al.  MicroRNA-137 inhibits autophagy and chemosensitizes pancreatic cancer cells by targeting ATG5. , 2019, The international journal of biochemistry & cell biology.

[7]  G. Martinelli,et al.  Novel Agents for Acute Myeloid Leukemia , 2018, Cancers.

[8]  Wei Tang,et al.  NPRL2 enhances autophagy and the resistance to Everolimus in castration‐resistant prostate cancer , 2018, The Prostate.

[9]  Xin Xiao,et al.  HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma , 2018, Journal of Experimental & Clinical Cancer Research.

[10]  J. Rinn,et al.  An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance , 2018, Cell.

[11]  J. Gribben,et al.  The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia , 2017, Nature Communications.

[12]  Angela N. Brooks,et al.  A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles , 2017, Cell.

[13]  T. Hwang,et al.  Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis , 2017, The Kaohsiung journal of medical sciences.

[14]  Bob Löwenberg,et al.  Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. , 2017, Blood.

[15]  Hongwei Liang,et al.  MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy , 2017, Cell Death & Disease.

[16]  D. Peeper,et al.  Autophagy-mediated degradation of nuclear envelope proteins during oncogene-induced senescence. , 2015, Carcinogenesis.

[17]  K. Chibale,et al.  Chloroquine-containing compounds: a patent review (2010 – 2014) , 2015, Expert opinion on therapeutic patents.

[18]  W. Zhan,et al.  Oxamate-mediated inhibition of lactate dehydrogenase induces protective autophagy in gastric cancer cells: involvement of the Akt-mTOR signaling pathway. , 2015, Cancer letters.

[19]  L. Klampfer,et al.  K-Ras, intestinal homeostasis and colon cancer. , 2015, Current clinical pharmacology.

[20]  S. Aliño,et al.  Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies , 2015, The Pharmacogenomics Journal.

[21]  A. Vincent-Salomon,et al.  Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers , 2014, Autophagy.

[22]  Lin Zhao,et al.  Different effects of LDH-A inhibition by oxamate in non-small cell lung cancer cells , 2014, Oncotarget.

[23]  Donna D. Zhang,et al.  Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells , 2014, Molecular medicine reports.

[24]  L. Galluzzi,et al.  Chloroquine and hydroxychloroquine for cancer therapy , 2014, Molecular & cellular oncology.

[25]  R. Ganapathi,et al.  Mechanisms regulating resistance to inhibitors of topoisomerase II , 2013, Front. Pharmacol..

[26]  Sridhar Ramaswamy,et al.  Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..

[27]  Jarek Meller,et al.  VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. , 2012, Cancer cell.

[28]  H. Coller,et al.  Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. , 2011, Genes & development.

[29]  Eileen White,et al.  Autophagy and Metabolism , 2010, Science.

[30]  Z. Elazar,et al.  LC3 and GATE‐16/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis , 2010, The EMBO journal.

[31]  E. Estey,et al.  Treatment of acute myeloid leukemia , 2009, Haematologica.

[32]  Robert A. Weinberg,et al.  Ras oncogenes: split personalities , 2008, Nature Reviews Molecular Cell Biology.

[33]  C. Chong,et al.  New uses for old drugs , 2007, Nature.

[34]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[35]  Kevin Bray,et al.  Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. , 2006, Cancer cell.

[36]  J. Sotelo,et al.  Adding Chloroquine to Conventional Treatment for Glioblastoma Multiforme , 2006, Annals of Internal Medicine.

[37]  R. Mesa,et al.  Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine. , 2005, Blood.

[38]  D. Parry,et al.  Chk1 is Essential for Tumor Cell Viability Following Activation of the Replication Checkpoint , 2005, Cell cycle.

[39]  R. Willemze,et al.  Deoxycytidine kinase expression and activity in patients with resistant versus sensitive acute myeloid leukemia , 2002, European journal of haematology.

[40]  Takeshi Tokuhisa,et al.  Dissection of Autophagosome Formation Using Apg5-Deficient Mouse Embryonic Stem Cells , 2001, The Journal of cell biology.

[41]  Jacob D. Jaffe,et al.  Next-generation characterization of the Cancer Cell Line Encyclopedia , 2019, Nature.